Nita Nair
YOU?
Author Swipe
View article: Audio Deepfake Detection Using MFCC-SVM, CQCC-GMM, and Spectrogram-CNN: A Comparative Study
Audio Deepfake Detection Using MFCC-SVM, CQCC-GMM, and Spectrogram-CNN: A Comparative Study Open
View article: Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial Open
PURPOSE We evaluated the survival impact of adding platinum to standard taxane-anthracycline neoadjuvant chemotherapy in triple-negative breast cancer (TNBC). METHODS In this phase III trial, patients with TNBC were randomly assigned, afte…
View article: From the Desk of Editors: Omission of Surgery in Breast Cancer? Step Forward or Detour
From the Desk of Editors: Omission of Surgery in Breast Cancer? Step Forward or Detour Open
View article: Artificial intelligence powered crime scene analysis service
Artificial intelligence powered crime scene analysis service Open
View article: Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy Open
PURPOSE There are scant data on patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer treated with neoadjuvant therapy (NAT) in real-world settings with limited access to HER2-targeted therapy. METHODS This w…
View article: P164: Burden of clinico-radiological N3 lymphadenopathy in nonmetastatic breast cancer- single centre experience
P164: Burden of clinico-radiological N3 lymphadenopathy in nonmetastatic breast cancer- single centre experience Open
View article: P310: Phase-3 Randomized Controlled Trial Assessing Cosmetic Outcomes in Patients Undergoing Standard Breast Conservation Surgery With or Without Deep Suture Approximation of the Primary Surgical Cavity
P310: Phase-3 Randomized Controlled Trial Assessing Cosmetic Outcomes in Patients Undergoing Standard Breast Conservation Surgery With or Without Deep Suture Approximation of the Primary Surgical Cavity Open
View article: P313: Assessment of Surgical Margins in Breast Conservation Surgery Using Intraoperative Imaging Techniques (ASSIsT)- a prospective, single center study
P313: Assessment of Surgical Margins in Breast Conservation Surgery Using Intraoperative Imaging Techniques (ASSIsT)- a prospective, single center study Open
View article: P165: Ipsilateral Supraclavicular Lymphadenopathy in Advanced, Non-Metastatic Breast Cancer- 8-Year Outcome Analysis
P165: Ipsilateral Supraclavicular Lymphadenopathy in Advanced, Non-Metastatic Breast Cancer- 8-Year Outcome Analysis Open
View article: P450: Patterns of presentation, recurrence and propensity score matched outcome analysis of invasive lobular carcinoma- a tertiary care cancer centre experience
P450: Patterns of presentation, recurrence and propensity score matched outcome analysis of invasive lobular carcinoma- a tertiary care cancer centre experience Open
View article: Correction to: Principles of Surgical Oncology
Correction to: Principles of Surgical Oncology Open
View article: Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid‐Free Regimen Using <i>Tinospora cordifolia</i>—A Single‐Institution Experience
Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid‐Free Regimen Using <i>Tinospora cordifolia</i>—A Single‐Institution Experience Open
Introduction: Idiopathic granulomatous mastitis (IGM) is a benign, chronic inflammatory disease with no effective treatment and high relapse rate. The pathophysiology is poorly understood. Tinosporin, an immunomodulator obtained from Tinos…
View article: Prevalence of Distant Metastases in High-Risk Operable Breast Cancer (HROBC) pT1-2 N2a or Higher at Diagnosis
Prevalence of Distant Metastases in High-Risk Operable Breast Cancer (HROBC) pT1-2 N2a or Higher at Diagnosis Open
Current standard guidelines do not recommend a routine staging workup in early operable breast cancer (OBC) as the incidence of de novo metastasis is only 1–2%. Some of these patients are at high risk for relapse based on the higher axilla…
View article: Management of BRCA-associated breast cancer patients in low and middle-income countries: a review
Management of BRCA-associated breast cancer patients in low and middle-income countries: a review Open
Breast cancer poses a significant global health challenge, with higher incidence rates in developed countries. However, low- and middle-income countries (LMICs) suffer from higher mortality rates due to various factors, including limited s…
View article: Under-representation of older Indian persons with cancer in clinical trials
Under-representation of older Indian persons with cancer in clinical trials Open
Objective Older patients with cancer have traditionally been under-represented in global clinical trials. There are no data from India regarding this issue. Methods and analysis This was a retrospective analysis done at our institute on in…
View article: Supplementary Table 8 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 8 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 8 shows the Genes included in qPCR validation.
View article: Supplementary Figure 4 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Figure 4 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Figure 4 shows the ClueGO Gene Ontology analysis for 85 genes de-regulated in both patient-specific analysis and replicate analysis for breast cancer RNA-Seq data.
View article: Supplementary Table 3 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 3 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 3 shows the Hallmarks, Canonical Pathways, and Gene Ontologies with FDR q-value <0.05 enriched in MSigDB for significantly de-regulated genes in each comparison (AvB, BvC and AvC) in individual patient time-series analy…
View article: Supplementary Figure 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Figure 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Figure 2 shows unsupervised clustering of Breast Cancer patients based on genome-wide expression counts.
View article: Supplementary Table 7 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 7 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 7 shows Genes de-regulated between various time-points during surgery in HNSCC Microarray data.
View article: Supplementary Table 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 2 shows the 4854 unique genes found to be de-regulated in any one comparison across all comparisons for AvB, BvC and AvC in for breast cancer individual patient specific RNA-Seq analysis.
View article: Supplementary Figure 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Figure 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Figure 1 shows the effect of various transformation methods on RNA-Seq data from breast cancer patients.
View article: Supplementary Table 7 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 7 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 7 shows Genes de-regulated between various time-points during surgery in HNSCC Microarray data.
View article: Supplementary Figure 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Figure 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Figure 2 shows unsupervised clustering of Breast Cancer patients based on genome-wide expression counts.
View article: Supplementary Table 5 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 5 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 5 shows the GO terms for 85 significantly de-regulated genes common to the individual patient time-series analysis and replicative analysis in Breast Cancer Patients.
View article: Supplementary Materials and Methods from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Materials and Methods from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Materials and Methods
View article: Data from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Data from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Surgery exposes tumor tissue to severe hypoxia and mechanical stress leading to rapid gene expression changes in the tumor and its microenvironment, which remain poorly characterized. We biopsied tumor and adjacent normal tissues from pati…
View article: Supplementary Table 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 1 shows the Breast cancer patient assay distribution and clinical info
View article: Supplementary Table 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 1 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 1 shows the Breast cancer patient assay distribution and clinical info
View article: Supplementary Table 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
Supplementary Table 2 from Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment Open
Supplementary Table 2 shows the 4854 unique genes found to be de-regulated in any one comparison across all comparisons for AvB, BvC and AvC in for breast cancer individual patient specific RNA-Seq analysis.